CD44 and breast cancer: Similar results have been obtained in breast cancer (MDA-MB-231) and osteosarcoma (MG-63 and U2OS) cell lines; CD44 knockout or CD44 silencing in these cell lines (which express high CD44 levels on basal conditions) drastically reduced the migration and invasion rate compared with wild-type cells [25,33].